Lyssikatos Joseph P

Enliven Therapeutics, Inc. · CHIEF SCIENTIFIC OFFICER

Lyssikatos Joseph P is listed in filings as CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 17, 2026, including sale activity. Recent filings connect the profile to Enliven Therapeutics, Inc. (ELVN). The current snapshot covers public activity from Jul 3, 2024 to Feb 17, 2026. Reported amounts are shown as $3.1M to $390.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Enliven Therapeutics, Inc.ELVN$390k14.5k sharesSellJan 20, 2026$26.90$53.20
Enliven Therapeutics, Inc.ELVN$145k5.5k sharesSellJan 20, 2026$26.37$53.20
Enliven Therapeutics, Inc.ELVN$1M50k sharesSellJan 9, 2026$29.13$53.20
Enliven Therapeutics, Inc.ELVN$1M41.2k sharesSellJan 9, 2026$24.90$53.20
Enliven Therapeutics, Inc.ELVN$842k33.8k sharesSellJan 8, 2026$24.92$53.20
Enliven Therapeutics, Inc.ELVN$151k7.5k sharesSellJan 8, 2026$20.13$53.20
Enliven Therapeutics, Inc.ELVN$84k5k sharesSellDec 19, 2025$16.84$53.20
Enliven Therapeutics, Inc.ELVN$268k12k sharesSellNov 19, 2025$22.30$53.20
Enliven Therapeutics, Inc.ELVN$11k492 sharesSellNov 19, 2025$23.09$53.20
Enliven Therapeutics, Inc.ELVN$276k12.5k sharesSellOct 20, 2025$22.08$53.20
Enliven Therapeutics, Inc.ELVN$81k4k sharesSellSep 26, 2025$20.25$53.20
Enliven Therapeutics, Inc.ELVN$30k1.5k sharesSellSep 23, 2025$20.03$53.20
Enliven Therapeutics, Inc.ELVN$93k4.9k sharesSellSep 19, 2025$19.11$53.20
Enliven Therapeutics, Inc.ELVN$43k2.1k sharesSellSep 19, 2025$20.02$53.20
Enliven Therapeutics, Inc.ELVN$150k7.5k sharesSellAug 21, 2025$20.01$53.20
Enliven Therapeutics, Inc.ELVN$98k5k sharesSellAug 19, 2025$19.62$53.20
Enliven Therapeutics, Inc.ELVN$265k11.9k sharesSellJul 21, 2025$22.26$53.20
Enliven Therapeutics, Inc.ELVN$13k576 sharesSellJul 21, 2025$22.90$53.20
Enliven Therapeutics, Inc.ELVN$267k12.5k sharesSellJun 20, 2025$21.40$53.20
Enliven Therapeutics, Inc.ELVN$150k7.5k sharesSellJun 3, 2025$20.03$53.20
Enliven Therapeutics, Inc.ELVN$82k5k sharesSellMay 19, 2025$16.31$53.20
Enliven Therapeutics, Inc.ELVN$49k2.5k sharesSellMay 2, 2025$20.01$53.20
Enliven Therapeutics, Inc.ELVN$101k5k sharesSellMay 1, 2025$20.07$53.20
Enliven Therapeutics, Inc.ELVN$75k4.7k sharesSellApr 21, 2025$16.03$53.20
Enliven Therapeutics, Inc.ELVN$5.5k330 sharesSellApr 21, 2025$16.72$53.20
Enliven Therapeutics, Inc.ELVN$258k12.5k sharesSellMar 19, 2025$20.61$53.20
Enliven Therapeutics, Inc.ELVN$25k847 sharesSellOct 18, 2024$30.00$53.20
Enliven Therapeutics, Inc.ELVN$964k34.3k sharesSellOct 9, 2024$28.12$53.20
Enliven Therapeutics, Inc.ELVN$102k3.6k sharesSellOct 9, 2024$28.52$53.20
Enliven Therapeutics, Inc.ELVN$368k13.2k sharesSellOct 8, 2024$27.96$53.20
Enliven Therapeutics, Inc.ELVN$2.9k100 sharesSellOct 8, 2024$28.51$53.20
Enliven Therapeutics, Inc.ELVN$75k2.7k sharesSellOct 7, 2024$27.61$53.20
Enliven Therapeutics, Inc.ELVN$207k7.5k sharesSellOct 4, 2024$27.51$53.20
Enliven Therapeutics, Inc.ELVN$15k527 sharesSellOct 1, 2024$27.54$53.20
Enliven Therapeutics, Inc.ELVN$269k12k sharesSellAug 29, 2024$22.48$53.20
Enliven Therapeutics, Inc.ELVN$1.2k50 sharesSellAug 29, 2024$23.08$53.20
Enliven Therapeutics, Inc.ELVN$85k3.1k sharesSellJul 31, 2024$27.56$53.20
Enliven Therapeutics, Inc.ELVN$315k11.8k sharesSellJul 29, 2024$26.69$53.20
Enliven Therapeutics, Inc.ELVN$5.6k203 sharesSellJul 29, 2024$27.43$53.20
Enliven Therapeutics, Inc.ELVN$275k12k sharesSellJul 1, 2024$22.89$53.20